PROSPECTS FOR THE USE OF MELATONIN IN COMPREHENSIVE TREATMENT FOR WOMEN WITH HORMONAL INFERTILITY

The study of melatonin levels in women of reproductive age with PCOS and endometriosis is a promising direction, which makes it possible to more accurately determine treatment tactics for women with PCOS with different phenotypes and external genital endometriosis. The results obtained demonstrate the need to include the determination of melatonin in women of reproductive age with PCOS and external genital endometriosis as an additional diagnostic criterion for making a diagnosis and determining further management tactics.